Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Journal of Toxicology and Environmental Health. Part A|May 2, 2022
Evaluating risk, exposure, and detection capabilities for chemical threats in waterMarisa Pfohl, Erin Silvestri, John C Lipscomb, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 18, 2020
Comparison of in vivo derived and scaled in vitro metabolic rate constants for several volatile organic compounds (VOCs)Elaina M Kenyon, Christopher Eklund, Rex A Pegram, et al.Environmental Health Perspectives|September 13, 2006
Issues in the pharmacokinetics of trichloroethylene and its metabolitesWeihsueh A Chiu, Miles S Okino, John C Lipscomb, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 26, 2010
Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurementsChristopher S Mazur, John F Kenneke, Janet K Hess-Wilson, et al.Toxicology Mechanisms and Methods|December 22, 2009
Cold and cryopreservation of monkey liver slicesRobyn L Fisher, Steven J Hasal, John C Lipscomb, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|December 4, 2003
The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humansJohn C Lipscomb, Linda K Teuschler, Jeff Swartout, et al.Journal of Toxicology and Environmental Health. Part A|June 19, 2007
In vitro metabolism of the fungicide and environmental contaminant trans-bromuconazole and implications for risk assessmentChristopher S Mazur, John F Kenneke, Caroline Tebes-Stevens, et al.Journal of Toxicology and Environmental Health. Part A|June 15, 2004
A feasibility study of cumulative risk assessment methods for drinking water disinfection by-product mixturesLinda K Teuschler, Glenn E Rice, Charles R Wilkes, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|September 26, 2018
The Impact of Scaling Factor Variability on Risk-Relevant Pharmacokinetic Outcomes in Children: A Case Study Using Bromodichloromethane (BDCM)Elaina M Kenyon, John C Lipscomb, Rex A Pegram, et al.Regulatory Toxicology and Pharmacology : RTP|March 29, 2013
Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessmentM E Bette Meek, Hugh A Barton, Jos G Bessems, et al.Pageof 4